Crohn's disease: Difference between revisions
Ostermayer (talk | contribs) (Prepared the page for translation) |
Ostermayer (talk | contribs) (Marked this version for translation) |
||
| Line 2: | Line 2: | ||
<translate> | <translate> | ||
==Background== | ==Background== <!--T:1--> | ||
<!--T:2--> | |||
*Can involve any part of the GI tract from the mouth to the anus | *Can involve any part of the GI tract from the mouth to the anus | ||
*Bimodal distribution: 15-22yr, 55-60yr | *Bimodal distribution: 15-22yr, 55-60yr | ||
| Line 16: | Line 17: | ||
==Clinical Features== | ==Clinical Features== <!--T:3--> | ||
<!--T:4--> | |||
[[File:Aphthous stomatitis.jpg|thumb|An aphthous mouth ulcer ([[Special:MyLanguage/aphthous stomatitis|aphthous stomatitis]]) on seen with Crohn's disease.]] | [[File:Aphthous stomatitis.jpg|thumb|An aphthous mouth ulcer ([[Special:MyLanguage/aphthous stomatitis|aphthous stomatitis]]) on seen with Crohn's disease.]] | ||
[[File:A single EN.jpg|thumb|A single lesion of erythema nodosum.]] | [[File:A single EN.jpg|thumb|A single lesion of erythema nodosum.]] | ||
===GI Symptoms=== | ===GI Symptoms=== <!--T:5--> | ||
<!--T:6--> | |||
*[[Special:MyLanguage/Abdominal pain|Abdominal pain]] | *[[Special:MyLanguage/Abdominal pain|Abdominal pain]] | ||
*[[Special:MyLanguage/Diarrhea|Diarrhea]] | *[[Special:MyLanguage/Diarrhea|Diarrhea]] | ||
| Line 29: | Line 32: | ||
===Extraintestinal Symptoms (50%)=== | ===Extraintestinal Symptoms (50%)=== <!--T:7--> | ||
<!--T:8--> | |||
*[[Special:MyLanguage/Arthritis|Arthritis]] | *[[Special:MyLanguage/Arthritis|Arthritis]] | ||
**Peripheral [[Special:MyLanguage/arthritis|arthritis]] | **Peripheral [[Special:MyLanguage/arthritis|arthritis]] | ||
| Line 60: | Line 64: | ||
==Differential Diagnosis== | ==Differential Diagnosis== <!--T:9--> | ||
</translate> | </translate> | ||
| Line 66: | Line 70: | ||
<translate> | <translate> | ||
===Other=== | ===Other=== <!--T:10--> | ||
<!--T:11--> | |||
*[[Special:MyLanguage/Appendicitis|Appendicitis]] | *[[Special:MyLanguage/Appendicitis|Appendicitis]] | ||
==Evaluation== | ==Evaluation== <!--T:12--> | ||
===Work-Up=== | ===Work-Up=== <!--T:13--> | ||
<!--T:14--> | |||
*Rule out alternate etiologies for symptoms | *Rule out alternate etiologies for symptoms | ||
*Evaluate for complications (e.g. fistulae, abscess, obstruction) | *Evaluate for complications (e.g. fistulae, abscess, obstruction) | ||
| Line 88: | Line 94: | ||
***[[Special:MyLanguage/Clostridium difficile|C.diff]] toxin | ***[[Special:MyLanguage/Clostridium difficile|C.diff]] toxin | ||
<!--T:15--> | |||
*Consider imaging: | *Consider imaging: | ||
**CT A/P if concern for [[Special:MyLanguage/small bowel obstruction|small bowel obstruction]], perforation, or toxic megacolon | **CT A/P if concern for [[Special:MyLanguage/small bowel obstruction|small bowel obstruction]], perforation, or toxic megacolon | ||
| Line 94: | Line 101: | ||
===Diagnosis=== | ===Diagnosis=== <!--T:16--> | ||
==Management== | ==Management== <!--T:17--> | ||
<!--T:18--> | |||
[[File:CT scan gastric CD.jpg|thumb|CT scan showing Crohn's disease in the fundus of the stomach.]] | [[File:CT scan gastric CD.jpg|thumb|CT scan showing Crohn's disease in the fundus of the stomach.]] | ||
===Acute Flare Management=== | ===Acute Flare Management=== <!--T:19--> | ||
<!--T:20--> | |||
*[[Special:MyLanguage/IVF|IVF]] | *[[Special:MyLanguage/IVF|IVF]] | ||
*Bowel rest | *Bowel rest | ||
| Line 113: | Line 122: | ||
===Chronic Treatment=== | ===Chronic Treatment=== <!--T:21--> | ||
<!--T:22--> | |||
''Alterations should be discussed with GI'' | ''Alterations should be discussed with GI'' | ||
*Aminosalicylates (5-ASA) - Mild-to-moderate Crohn's disease. Give with probiotics. | *Aminosalicylates (5-ASA) - Mild-to-moderate Crohn's disease. Give with probiotics. | ||
| Line 145: | Line 155: | ||
==Disposition== | ==Disposition== <!--T:23--> | ||
===Inpatient Admission=== | ===Inpatient Admission=== <!--T:24--> | ||
<!--T:25--> | |||
*Significant metabolic derangements (i.e. [[Special:MyLanguage/electrolyte imbalance|electrolyte imbalance]] or severe [[Special:MyLanguage/dehydration|dehydration]]) | *Significant metabolic derangements (i.e. [[Special:MyLanguage/electrolyte imbalance|electrolyte imbalance]] or severe [[Special:MyLanguage/dehydration|dehydration]]) | ||
*Fulminate [[Special:MyLanguage/colitis|colitis]] | *Fulminate [[Special:MyLanguage/colitis|colitis]] | ||
| Line 157: | Line 168: | ||
===Surgical Intervention=== | ===Surgical Intervention=== <!--T:26--> | ||
<!--T:27--> | |||
''Consult EARLY if any of the following suspicions'' | ''Consult EARLY if any of the following suspicions'' | ||
*Perforation | *Perforation | ||
| Line 169: | Line 181: | ||
==Complications== | ==Complications== <!--T:28--> | ||
<!--T:29--> | |||
*[[Special:MyLanguage/Bowel obstruction|Bowel obstruction]] | *[[Special:MyLanguage/Bowel obstruction|Bowel obstruction]] | ||
**Due to stricture or bowel wall edema | **Due to stricture or bowel wall edema | ||
| Line 189: | Line 202: | ||
===Therapy complications=== | ===Therapy complications=== <!--T:30--> | ||
<!--T:31--> | |||
*[[Special:MyLanguage/Leukopenia|Leukopenia]]/[[Special:MyLanguage/thrombocytopenia|thrombocytopenia]] | *[[Special:MyLanguage/Leukopenia|Leukopenia]]/[[Special:MyLanguage/thrombocytopenia|thrombocytopenia]] | ||
*[[Special:MyLanguage/Fever|Fever]]/infection | *[[Special:MyLanguage/Fever|Fever]]/infection | ||
| Line 197: | Line 211: | ||
==See Also== | ==See Also== <!--T:32--> | ||
<!--T:33--> | |||
*[[Special:MyLanguage/Ulcerative Colitis|Ulcerative Colitis]] | *[[Special:MyLanguage/Ulcerative Colitis|Ulcerative Colitis]] | ||
*[[Special:MyLanguage/Colitis|Colitis]] | *[[Special:MyLanguage/Colitis|Colitis]] | ||
==References== | ==References== <!--T:34--> | ||
<!--T:35--> | |||
<references/> | <references/> | ||
[[Category:GI]] | [[Category:GI]] | ||
1. Thomas N, Wu AW. Large intestine. In: Walls RM, Hockberger RS, Gausche-Hill M, et al., eds. Rosen’s Emergency Medicine: Concepts and Clinical Practice. 10th ed. Elsevier; 2023. | 1. Thomas N, Wu AW. Large intestine. In: Walls RM, Hockberger RS, Gausche-Hill M, et al., eds. Rosen’s Emergency Medicine: Concepts and Clinical Practice. 10th ed. Elsevier; 2023. | ||
</translate> | </translate> | ||
Latest revision as of 12:54, 14 January 2026
Background
- Can involve any part of the GI tract from the mouth to the anus
- Bimodal distribution: 15-22yr, 55-60yr
- Pathology
- All layers of the bowel are involved
- Reason why fistulas and abscesses are common complications
- "Skip lesions" are common
- All layers of the bowel are involved
Crohn's disease vs. ulcerative colitis
| Finding | Crohn's disease | Ulcerative colitis |
| Depth of inflammation | May be transmural, deep into tissues | Shallow, mucosal |
| Distribution of disease | Patchy areas of inflammation (skip lesions) | Continuous area of inflammation |
| Terminal ileum involvement | Commonly | Seldom |
| Colon involvement | Usually | Always |
| Rectum involvement | Seldom | Usually (95%) |
| Involvement around anus | Common | Seldom |
| Stenosis | Common | Seldom |
Clinical Features
An aphthous mouth ulcer (aphthous stomatitis) on seen with Crohn's disease.
GI Symptoms
- Abdominal pain
- Diarrhea
- Weight loss
- Perianal fissures or fistulas
Extraintestinal Symptoms (50%)
- Arthritis
- Peripheral arthritis
- Migratory monoarticular or polyarticular
- Ankylosing spondylitis
- Pain/stiffness of spine, hips, neck, rib cage
- Sacroiliitis
- Low back pain with morning stiffness
- Peripheral arthritis
- Ocular
- Uveitis
- Acute blurring of vision, photophobia, pain, perilimbic scleral injection
- Episcleritis
- Eye burning or itching with out visual changes or pain; scleral and conj hyperemia
- Uveitis
- Dermatologic
- Erythema nodosum
- Painful, red, raised nodules on extensor surfaces of arms/legs
- Pyoderma gangrenosum
- Violaceous, ulcerative lesions with necrotic center found in pretibial region or trunk
- Erythema nodosum
- Hepatobiliary
- Cholelithiasis (33%)
- Fatty liver
- Autoimmune hepatitis
- Primary sclerosing cholangitis
- Cholangiocarcinoma
- Renal
- Increased risk for calcium oxalate stones due to hyperoxaluria
- Vascular
Differential Diagnosis
Colitis
- Viral gastroenteritis
- Bacterial gastroenteritis
- Campylobacter infections
- Clostridium difficile colitis
- Colon cancer
- Crohn disease
- Cryptosporidiosis
- Mycobacterium Avium-Intracellulare
- Toxic megacolon
- Ulcerative colitis
- Ischemic bowel disease (e.g. mesenteric ischemia, strangulated hernia)
- Pseudomembranous enterocolitis
- Lymphoma
- Ileocecal amebiasis
- Sarcoidosis
- Yersinia
- Campylobacter
Other
Evaluation
Work-Up
- Rule out alternate etiologies for symptoms
- Evaluate for complications (e.g. fistulae, abscess, obstruction)
- Labs
- Consider imaging:
- CT A/P if concern for small bowel obstruction, perforation, or toxic megacolon
- Most useful diagnostic test in patients with acute symptoms who have known or suspected Crohn
- Findings: bowel wall thickening, mesenteric edema, local abscess, fistulas
- CT A/P if concern for small bowel obstruction, perforation, or toxic megacolon
Diagnosis
Management
Acute Flare Management
- IVF
- Bowel rest
- Analgesia
- Electrolyte correction
- Consider steroid burst
- Methylprednisolone (e.g., 30mg IV bid) or prednisone (e.g., 60 mg day 1, then 40 mg daily x 4 days), OR
- Budesonide for mild to moderate disease due to fewer systemic side effects
- Antidiarrheals are contraindicated
Chronic Treatment
Alterations should be discussed with GI
- Aminosalicylates (5-ASA) - Mild-to-moderate Crohn's disease. Give with probiotics.
- Sulfasalazine 3-5gm/day PO (sulfa drug)
- Caution: Can cause folate deficiency so give with folic acid, and can cause hemolytic anemia in G6PD patients
- Mesalamine 4gm/day PO
- Active moiety of sulfasalazine, and formed from prodrug balsalazide
- Balsalazide or Olsalazine - Bypasses small intestine to deliver drug into large intestine (better for UC)
- Sulfasalazine 3-5gm/day PO (sulfa drug)
- Anti-diarrheal - Use caution in patients with active inflammation as can precipitate toxic megacolon
- Loperamide 4-16mg/day
- Diphenoxylate 5-20mg/day
- Cholestyramine 4g once to six times daily
- Glucocorticoids - Symptomatic relief (course not altered)
- Prednisone - 40-60mg/day with taper once remission induced
- Methylprednisolone 20mg IV q6hr
- Hydrocortisone 100mg q8hr
- Do not start if any suspicion of infection (ie C. diff colitis)
- Double edge sword: Reduction of bone density in addition to underlying disease process(decreased Ca absorption)
- Antibiotics - Induce remission
- Ciprofloxacin 500mg q8-12hr OR
- Metronidazole 500mg q6hr OR
- Rifaximin 800mg BID
- Immunomodulators - Steroid-sparing agents used in fistulas and patients with surgical contraindication. Slower onset.
- 6-Mercaptopurine 1-1.5mg/kg/day → Start at 50mg daily
- Azathioprine 2-2.5mg/kg/day → Start at 50mg daily
- Methotrexate IM
- Anti-TNF - Medically resistant moderate-to-severe Crohn's disease
- Infliximab (Remicade) 5mg/kg IV
- Adalimumab (Humira), Natalizumab or certolizumab pegol can also be used
Disposition
Inpatient Admission
- Significant metabolic derangements (i.e. electrolyte imbalance or severe dehydration)
- Fulminate colitis
- Obstruction
- Peritonitis
- Significant hemorrhage
Surgical Intervention
Consult EARLY if any of the following suspicions
- Perforation
- Abscess/fistula formation
- Toxic megacolon
- Significant hemorrhage
- Perianal disease
- Failed medical management
Complications
- Bowel obstruction
- Due to stricture or bowel wall edema
- Abscess
- Fistula
- Occurs due to extension of intestinal fissure into adjacent structures
- Suspect if changes in patient's symptoms (e.g. BM frequency, amt of pain, wt loss)
- Perianal disease
- Hemorrhage
- Erosion into a bowel wall vesel
- Toxic megacolon
- Can be associated with massive GI bleeding
Therapy complications
See Also
References
- ↑ van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ. 2010;15(341):c3369.
1. Thomas N, Wu AW. Large intestine. In: Walls RM, Hockberger RS, Gausche-Hill M, et al., eds. Rosen’s Emergency Medicine: Concepts and Clinical Practice. 10th ed. Elsevier; 2023.
